Literature DB >> 15331187

Occupational interstitial lung disease.

Craig S Glazer1, Lee S Newman.   

Abstract

Occupational interstitial lung diseases are a diverse group of disorders of varied cause. Occupational causes account for a significant portion of all interstitial lung diseases, and new causes continue to be described. Although some are diseases of antiquity, they continue to occur in the workplace and often are misdiagnosed as "idiopathic" when physicians miss the connection to past-inhaled exposures. All of these diseases are preventable with reduction or elimination of workplace exposure. This article reviews the spectrum of diseases caused by exposure to metal dust and fumes, inorganic fibers, and nonfibrous inorganic dust. It also details an approach to the diagnosis, evaluation, and management of this group of illnesses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331187     DOI: 10.1016/j.ccm.2004.04.004

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  8 in total

1.  Pulmonary inflammation triggered by ricin toxin requires macrophages and IL-1 signaling.

Authors:  Meghan L Lindauer; John Wong; Yoichiro Iwakura; Bruce E Magun
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

Review 2.  Asbestosis and environmental causes of usual interstitial pneumonia.

Authors:  Mridu Gulati; Carrie A Redlich
Journal:  Curr Opin Pulm Med       Date:  2015-03       Impact factor: 3.155

Review 3.  Newly recognized occupational and environmental causes of chronic terminal airways and parenchymal lung disease.

Authors:  Maor Sauler; Mridu Gulati
Journal:  Clin Chest Med       Date:  2012-12       Impact factor: 2.878

4.  Amiodarone-Induced Pulmonary Toxicity - A Frequently Missed Complication.

Authors:  Alexander J Sweidan; Navneet K Singh; Natasha Dang; Vinh Lam; Jyoti Datta
Journal:  Clin Med Insights Case Rep       Date:  2016-10-09

5.  Study of Clinico-Radiological Profiles of Patients with Occupational Interstitial Lung Disease in a Tertiary Care Center.

Authors:  Sameer Vaidya; Dipti Gothi; Mahismita Patro; U C Ojha; Ram Babu Sah
Journal:  Indian J Occup Environ Med       Date:  2020-03-18

6.  Pulmonary siderosis cases diagnosed with minimally invasive surgical technique: A retrospective analysis of 7 cases.

Authors:  Erkan Akar; Tekin Yildiz; Safak Atahan
Journal:  Ann Thorac Med       Date:  2018 Jul-Sep       Impact factor: 2.219

Review 7.  Progression in the Management of Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases, Where Are We Now and Where We Would Like to Be.

Authors:  Tinne Goos; Laurens J De Sadeleer; Jonas Yserbyt; Geert M Verleden; Marie Vermant; Stijn E Verleden; Wim A Wuyts
Journal:  J Clin Med       Date:  2021-03-23       Impact factor: 4.241

8.  The benefits of exercise training in interstitial lung disease: protocol for a multicentre randomised controlled trial.

Authors:  Leona Dowman; Christine F McDonald; Catherine Hill; Annemarie Lee; Kathryn Barker; Claire Boote; Ian Glaspole; Nicole Goh; Annemarie Southcott; Angela Burge; Rebecca Ndongo; Alicia Martin; Anne E Holland
Journal:  BMC Pulm Med       Date:  2013-02-01       Impact factor: 3.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.